Education
About Us
Working with TipRanks
Follow Us
Medicamen Biotech Limited (IN:MEDICAMEQ)
:MEDICAMEQ
MEDICAMEQ Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹377.00 - ₹630.00
Previous CloseN/A
Volume10.37K
Average Volume (3M)3.38K
Market Cap
₹5.42B
Enterprise Value₹7.33B
Total Cash (Recent Filing)₹73.50M
Total Debt (Recent Filing)₹117.55M
Price to Earnings (P/E)64.2
Beta1.62
Next Earnings
May 28, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 19, 2024Dividend Yield0.23%
Share Statistics
EPS (TTM)6.64
Shares Outstanding12,714,600
10 Day Avg. Volume1,810
30 Day Avg. Volume3,384
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
MEDICAMEQ FAQ
What was Medicamen Biotech Limited’s price range in the past 12 months?
Medicamen Biotech Limited lowest stock price was ₹377.00 and its highest was ₹630.00 in the past 12 months.
What is Medicamen Biotech Limited’s market cap?
Medicamen Biotech Limited’s market cap is ₹5.42B.
When is Medicamen Biotech Limited’s upcoming earnings report date?
Medicamen Biotech Limited’s upcoming earnings report date is May 28, 2025 which is in 26 days.
How were Medicamen Biotech Limited’s earnings last quarter?
Medicamen Biotech Limited released its earnings results on Feb 11, 2025. The company reported ₹2.746 earnings per share for the quarter, beating the consensus estimate of N/A by ₹2.746.
Is Medicamen Biotech Limited overvalued?
According to Wall Street analysts Medicamen Biotech Limited’s price is currently Overvalued.
Does Medicamen Biotech Limited pay dividends?
Medicamen Biotech Limited pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.23%. See more information on Medicamen Biotech Limited dividends here
What is Medicamen Biotech Limited’s EPS estimate?
Medicamen Biotech Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medicamen Biotech Limited have?
Medicamen Biotech Limited has 12,714,600 shares outstanding.
What happened to Medicamen Biotech Limited’s price movement after its last earnings report?
Medicamen Biotech Limited reported an EPS of ₹2.746 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -5.002%.
Which hedge fund is a major shareholder of Medicamen Biotech Limited?
Currently, no hedge funds are holding shares in IN:MEDICAMEQ
---
Technical Analysis
Aurobindo Pharma Ltd
―
Cipla Ltd
―
Dr. Reddy's Laboratories Ltd.
―
Lupin Limited
―
Sun Pharmaceutical Industries Limited
―
---